Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001219 · ClinicalTrials.gov registry record
Comparing Magnetic Resonance Imaging/Spectroscopy Techniques
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Terminated
- Registry status
- 49,946
- Enrollment target
NCT00001219 is a clinical trial that was terminated before completion, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 49,946 participants.
The verdict
NCT00001219 was terminated before completion, sponsored by National Institutes of Health Clinical Center (CC).
- TERMINATED
- Registry status
- 49,946 participants
- Enrollment target
Study Summary
Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are diagnostic tests that allow researchers to look at different chemical properties of tissue. Magnetic resonance imaging and spectroscopy studies can be used to gather or evaluate information about various aspects of patient s bodies or to monitor changes in the biochemistry and physiology of patient s bodies. Unlike other diagnostic techniques (CT scan and PET scan) MRI and MRS do not use ionizing radiation. Some studies have shown that MRI is more effective at distinguishing normal parts of the anatomy from abnormal anatomy, especially in the brain. MRI has become the diagnostic test of choice for evaluating patient with multiple sclerosis. The purpose of this study is to evaluate normal volunteers and patients with a variety of diseases with magnetic resonance imaging. Researchers will attempt different magnetic resonance imaging methods and techniques as well as different levels of magnetic strength.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49,946 participants |
| Start Date | 1987-06-18 |
| Est. Completion | 2020-06-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001219
The ClinicalTrials.gov registry entry for NCT00001219 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 49,946 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001219 about?
NCT00001219 is a clinical study titled "Comparing Magnetic Resonance Imaging/Spectroscopy Techniques". Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are diagnostic tests that allow researchers to look at different chemical properties of tissue. Magnetic resonance imaging and spectroscopy studies can be used to gather or evaluate information about various aspects of patien...
What is the current status of trial NCT00001219?
This trial is currently terminated. The enrollment target is 49,946 participants. The study started on 1987-06-18. Estimated completion is 2020-06-03.
Who is sponsoring clinical trial NCT00001219?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.